
Alto Ingredients, Inc. (NASDAQ:ALTO – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 EPS estimates for Alto Ingredients in a research note issued to investors on Thursday, March 5th. HC Wainwright analyst A. Dayal anticipates that the company will post earnings per share of ($0.08) for the quarter. The consensus estimate for Alto Ingredients’ current full-year earnings is ($0.37) per share. HC Wainwright also issued estimates for Alto Ingredients’ Q2 2026 earnings at $0.07 EPS, Q3 2026 earnings at $0.04 EPS, Q4 2026 earnings at $0.16 EPS, FY2026 earnings at $0.19 EPS and FY2027 earnings at $0.35 EPS.
A number of other brokerages also recently issued reports on ALTO. Wall Street Zen raised shares of Alto Ingredients from a “hold” rating to a “buy” rating in a research report on Sunday, November 16th. Zacks Research cut Alto Ingredients from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 1st. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alto Ingredients in a research note on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
Alto Ingredients Stock Performance
ALTO opened at $4.02 on Friday. The company’s 50 day moving average is $2.65 and its 200 day moving average is $1.96. The company has a current ratio of 3.56, a quick ratio of 2.30 and a debt-to-equity ratio of 0.45. The company has a market cap of $310.92 million, a price-to-earnings ratio of 25.13 and a beta of 0.60. Alto Ingredients has a 12-month low of $0.76 and a 12-month high of $4.20.
Alto Ingredients (NASDAQ:ALTO – Get Free Report) last released its quarterly earnings results on Wednesday, March 4th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.17. Alto Ingredients had a return on equity of 3.10% and a net margin of 1.45%.The firm had revenue of $231.97 million for the quarter, compared to the consensus estimate of $234.83 million.
Institutional Investors Weigh In On Alto Ingredients
Hedge funds have recently made changes to their positions in the stock. Peapod Lane Capital LLC raised its holdings in Alto Ingredients by 0.7% in the fourth quarter. Peapod Lane Capital LLC now owns 1,244,198 shares of the company’s stock worth $3,583,000 after purchasing an additional 9,074 shares in the last quarter. Vontobel Holding Ltd. purchased a new position in shares of Alto Ingredients in the 4th quarter worth approximately $33,000. XTX Topco Ltd raised its stake in shares of Alto Ingredients by 34.2% during the 4th quarter. XTX Topco Ltd now owns 52,753 shares of the company’s stock worth $152,000 after acquiring an additional 13,431 shares in the last quarter. Leonteq Securities AG purchased a new stake in Alto Ingredients during the fourth quarter valued at approximately $44,000. Finally, CreativeOne Wealth LLC purchased a new position in Alto Ingredients in the fourth quarter worth $46,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
More Alto Ingredients News
Here are the key news stories impacting Alto Ingredients this week:
- Positive Sentiment: Q4 2025 results showed a swing to profit with net income of $21.5M (reported) and materially higher adjusted EBITDA and gross profit; this supports the “return-to-profit” narrative that traders are front-running. Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2025 Results
- Positive Sentiment: HC Wainwright boosted FY2026 estimates (raised to $0.19 from $0.16) and projects FY2027 EPS of $0.35 — analyst upgrades reinforce a multi-quarter recovery story and likely add buying interest.
- Positive Sentiment: Management flagged a $15M target for 45Z tax credits tied to expanded CO2 operations and ongoing cost reductions — a structural earnings tailwind if realized. Alto Ingredients outlines $15M 45Z tax credit target for 2026 amid expanded CO2 operations and cost reductions
- Positive Sentiment: Unusual bullish options flow (large call buying) and media coverage pointing to the earnings surprise have amplified momentum traders’ interest. Why Alto Ingredients Stock Is Surging 50% Today
- Neutral Sentiment: Market commentary and valuation checks are active as investors reassess ALTO’s forward multiple now that the company is profitable again; watch valuation metrics relative to peers. Alto Ingredients (ALTO) Valuation Check After Return To Profit On 2025 Earnings Results
- Neutral Sentiment: Full earnings call transcript and slide deck are available for investors seeking more color on margin drivers and 2026 priorities. Alto Ingredients, Inc. (ALTO) Q4 2025 Earnings Call Transcript
- Negative Sentiment: Revenue marginally missed expectations ($231.97M vs. ~$234.8M consensus) and trailing net margin remains compressed (reportedly ~1.45%) — recovery is profit-driven but still uneven across top-line metrics. Alto Ingredients Q4 earnings summary
About Alto Ingredients
Alto Ingredients, Inc (NASDAQ: ALTO) is a diversified producer of alcohol-based products and specialty ingredients for industrial, food, beverage and personal care applications. The company’s core offering centers on ethanol produced for fuel markets, as well as an expanding portfolio of natural and organic alcohols, glycerin and other ingredient solutions. Alto’s product lines serve a range of end markets, including renewable fuels, confectionery, flavorings, cosmetics and sanitizers.
Headquartered in Dallas, Texas, Alto Ingredients operates a network of production facilities across the United States.
See Also
- Five stocks we like better than Alto Ingredients
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- 1,500 Banks Just Handed the Fed Your Bank Account
- Elon Musk’s $1 Quadrillion AI IPO
- [How To] Invest Pre-IPO In SpaceX With $100!
Receive News & Ratings for Alto Ingredients Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alto Ingredients and related companies with MarketBeat.com's FREE daily email newsletter.
